Pfizer to test COVID-19 vaccine in larger group of children under 12
(VOVWORLD) - Pfizer Inc and German partner BioNTech announced Tuesday that they will begin testing their COVID-19 vaccine on a larger group of children under 12.
 Pfizer-BioNTech vaccine doses of 30 micrograms are used for children over 12 in the EU, US, and Canada. |
The study will enroll some 4,500 children at 90 clinical sites in the United States, Finland, Poland, and Spain, the company said. Pfizer said it will use a dose of 10 micrograms for children between 5 and 11 and 3 micrograms for children under 5.
The company said in March that its vaccine is 100% effective in children ages 12-15.
According to US media, inoculating children more than 6 months old is considered a critical step toward reaching herd immunity and taming the COVID-19 pandemic.